Latest News

Purple Innovation, Inc. ( NASDAQ:PRPL ) shareholders won't be pleased to see that the share price has had a very rough...

Pinnacle West Capital Corporation ( NYSE:PNW ) came out with its quarterly results last week, and we wanted to see how...

As the U.S. stock market rebounds from a recent tech sector downturn, major indices like the Nasdaq, Dow Jones Industrial Average, and S&P 500 have shown resilience despite ongoing economic uncertainties such as the government shutdown and trade policy debates. In this fluctuating environment, identifying stocks that may be undervalued can offer potential opportunities for investors seeking to capitalize on discrepancies between current prices and estimated intrinsic values.

Offerpad Solutions Inc. ( NYSE:OPAD ) just released its latest quarterly report and things are not looking great. It...

It's been a good week for HealthStream, Inc. ( NASDAQ:HSTM ) shareholders, because the company has just released its...

It's shaping up to be a tough period for L.B. Foster Company ( NASDAQ:FSTR ), which a week ago released some...

As you might know, TrueBlue, Inc. ( NYSE:TBI ) just kicked off its latest quarterly results with some very strong...

Some Labcorp Holdings Inc. ( NYSE:LH ) shareholders may be a little concerned to see that the Independent Director...

Readers hoping to buy W.W. Grainger, Inc. ( NYSE:GWW ) for its dividend will need to make their move shortly, as the...

We'd be surprised if Helix Energy Solutions Group, Inc. ( NYSE:HLX ) shareholders haven't noticed that the Executive VP...

Columbus McKinnon Corporation's ( NASDAQ:CMCO ) recent soft profit numbers didn't appear to worry shareholders, as the...

Clarivate Plc ( NYSE:CLVT ) shareholders (or potential shareholders) will be happy to see that the Director, Kenneth...

Orion Group Holdings, Inc. ( NYSE:ORN ) just reported some strong earnings, and the market reacted accordingly with a...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Key Insights The considerable ownership by individual investors in Oncology Institute indicates that they collectively...

Adeia Inc. ( NASDAQ:ADEA ) missed earnings with its latest quarterly results, disappointing overly-optimistic...

Key Insights Given the large stake in the stock by institutions, 8x8's stock price might be vulnerable to their trading...

When you see that almost half of the companies in the Machinery industry in Canada have price-to-sales ratios (or...

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

The Morning Bull - US Market Morning Update Thursday, Nov, 6 2025 US stock futures are drifting lower this morning as investors weigh a jump in long-term bond yields and a new record for household debt. The prospect of higher borrowing costs and elevated debt levels is spurring fresh caution across the market and putting pressure on consumer-focused stocks, as investors focus on the risk that financial strain could temper the economy’s momentum. Act now to uncover undervalued stocks based on...

The subdued stock price reaction suggests that Envista Holdings Corporation's ( NYSE:NVST ) strong earnings didn't...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

SNDL (NasdaqCM:SNDL) has released its third quarter and nine month earnings for 2025, revealing higher sales and a narrower net loss compared to the same periods last year. These updates are sparking fresh investor interest. See our latest analysis for SNDL. SNDL’s share price has been on a rollercoaster this year. After a rally earlier in the quarter, it’s taken a breather with a 27.7% drop over the past month and a 14.4% fall in the last week, despite the latest earnings showing meaningful...

Rani Therapeutics Holdings (RANI) just made headlines with a new licensing agreement with Chugai Pharmaceutical. This deal brings over $1 billion in potential revenue for its RaniPill technology and boosts its financial flexibility. See our latest analysis for Rani Therapeutics Holdings. Momentum around Rani Therapeutics Holdings has accelerated sharply, with a 1-month share price return of nearly 400% and year-to-date gains over 70%. This reflects investor excitement after its Chugai deal...